| Healthy subjects (N = 16) | CAD patients (N = 29) | p-value |
---|---|---|---|
Age – years | |||
 Mean ± SD | 57 ± 21.2 | 58 ± 14.8 | 0.86 |
 Range | 25–80 | 37–83 |  |
Male --no. (%) | 8 (50) | 21 (67) | 0.37 |
Left Ventricular Ejection Fraction -- % | N/A | 59 ± 5.2 |  |
Coronary artery imaged: Total segments | 19 | 31 | Â |
 RCA alone --no. (%) | 11 (69) | 20 (69) | NS |
 LAD alone--no. (%) | 3 (19) | 7 (24) | NS |
 Both RCA and LAD --no. (%) | 2 (12) | 2 (7) | NS |
History of prior angioplasty | N/A | 9 (31) | Â |
History of CABG | N/A | 1 (3) | Â |
Significant multivessel CAD (>50% luminal stenosis in major epicardial coronary artery) | N/A | 7 (24) | Â |
Body Mass Index (Mean ± SD) (BMI, kg/m2) | 26.0 ± 5.2 | 27.1 ± 5.9 | 0.49 |
CAD risk factorsa Mean ± SD | 0 | 1.3 ± 0.8 | <0.001 |
ACE-inhibitor use --no. (%) | 0 | 12 (39) | <0.001 |
Beta-blocker use --no. (%) | 0 | 15 (48) | <0.001 |
Statin use --no. (%) | 0 | 20 (69) | <0.001 |